Get access to over 18 million research reports from over 1,700 sources.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
- private equity
- third-party document and information retrieval
- and much, much more…
|67||2012||Independent Chairman of the Board, representing Innoste SA|
|2011||Chief Executive Officer, Managing Director, Executive Director|
|2011||Chief Financial Officer, Chief Compliance Officer, Company Secretary|
|Chief Technology Officer|
|51||Chief Business Officer, Managing Director, Executive Director, representing of Gil Beyen BVBA|
- BRIEF-Tigenix Nv - Mesoblast Grants Access To Patents To Support Commercialization Of Adipose-Derived Mesenchymal Stem Cell Product Cx601 For Treatment Of Fistulae
- BRIEF-JP Morgan Chase & Co notifies 3.12 pct shareholding in Tigenix
- BRIEF-Tigenix announces approval of trade name for CX601 in Europe
- BRIEF-Tigenix announces partial conversion of bonds
- BRIEF-Tigenix obtains patent for Cx601 lead development program